Table 2 KEGG pathways enriched in secondary viral interactors
From: Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
Pathway Name | Pathway ID | Observed | Random | Odds Ratio | FDR | FDR-Corr |
|---|---|---|---|---|---|---|
Apoptosis | hsa04210 | 6 | 1.82 | 3.31 | 1.3E-04 | 1.9E-02 |
Cell cycle | hsa04110 | 10 | 2.87 | 3.48 | 3.6E-04 | 4.8E-02 |
Chronic myeloid leukemia | hsa05220 | 8 | 1.59 | 5.03 | 2.1E-05 | 3.2E-03 |
Colorectal cancer | hsa05210 | 7 | 2.13 | 3.28 | 9.3E-05 | 1.4E-02 |
ErbB signaling pathway | hsa04012 | 7 | 1.67 | 4.19 | 6.3E-05 | 9.5E-03 |
Glioma | hsa05214 | 7 | 0.76 | 9.26 | 6.2E-05 | 9.3E-03 |
Huntington's disease | hsa05040 | 6 | 0.34 | 17.41 | < 2.5E-06 | < 3.8E-04 |
Insulin signaling pathway | hsa04910 | 10 | 2.06 | 4.86 | 1.2E-04 | 1.8E-02 |
Melanoma | hsa05218 | 4 | 0.64 | 6.27 | 1.4E-04 | 2.0E-02 |
Notch signaling pathway | hsa04330 | 4 | 1.82 | 2.20 | < 2.5E-06 | < 3.8E-04 |
Olfactory transduction | hsa04740 | 4 | 0.16 | 25.66 | < 2.5E-06 | < 3.8E-04 |
Prostate cancer | hsa05215 | 5 | 1.04 | 4.79 | 2.9E-04 | 4.3E-02 |
Ubiquitin mediated proteolysis | hsa04120 | 10 | 3.02 | 3.31 | 2.0E-04 | 2.9E-02 |